From Princeton to Arden’s Prevage Daily Serum

Signum Dermalogix Inc., a private biopharmaceutical company, has entered into a partnership with Elizabeth Arden, Inc. focusing on a semi-exclusive global license for the cosmetic functional ingredient Arazine (N-acetyl-S-farnesyl-cysteine) as well as developing new screening methodologies to measure the anti-oxidant potential of Arden’s other product ingredients.

Arazine, which was initially discovered at Princeton University, possesses anti-inflammatory and anti-oxidant properties, making it an ideal complement with idebenone-ester as key ingredients in Elizabeth Arden’s Prevage Anti-aging + Intensive Repair Daily Serum product.

“We are excited about our partnership with Arden especially given their commitment to bringing a scientific approach to developing new and innovative skin care products. We believe this is just the beginning of a dynamic collaboration that will enable the development of a first in class line of skin care products,” said Maxwell Stock, CEO of Signum Dermalogix.